Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.